Logo image of ELOX

ELOXX PHARMACEUTICALS INC (ELOX) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:ELOX - US29014R2022 - Common Stock

3.82 USD
-0.23 (-5.68%)
Last: 10/13/2023, 8:00:02 PM
2.8 USD
-1.02 (-26.7%)
After Hours: 10/13/2023, 8:00:02 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
ELOX revenue by date.ELOX revenue by date.
80K80KN/A
-100.00%
177.29M
EBITDA
YoY % growth
ELOX ebitda by date.ELOX ebitda by date.
-7.49M-5.32M
28.97%
N/A
11.65%
N/A
-894.89%
-44.982M
-7.93%
N/A
41.81%
N/A
-124.39%
N/A
47.89%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
ELOX ebit by date.ELOX ebit by date.
-7.67M-5.41M
29.47%
N/A
12.38%
-45.449M
-891.14%
-53.267M
-7.62%
-37.052M
41.77%
-66.408M
-124.25%
-35.7M
47.86%
-21.42M
37.77%
-28.56M
-33.33%
-43.86M
-53.57%
-56.1M
-27.91%
105.89M
288.75%
Operating Margin
ELOX operating margin by date.ELOX operating margin by date.
-9,587.50%-6,762.50%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A59.73%
EPS
YoY % growth
ELOX eps by date.ELOX eps by date.
N/AN/AN/A-57.15-55.87
2.90%
-37.74
47.01%
-38.35
5.63%
-16.97
38.36%
-8.07
51.16%
-7.54
6.57%
-6.78
10.01%
-8.20
-20.90%
14.15
272.51%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 23 Q4 / 23
EPS
Q2Q % growth
-2.01
44.18%
-1.46
50.05%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
N/AN/A
EBIT
Q2Q % growth
-4.08M
42.87%
-4.975M
17.48%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2023
Q2Q % growth
-1.96
59.17%
-1.57-0.39-24.78%
Q1 2023
Q2Q % growth
-2.88
44.62%
-2.60-0.28-10.73%
Q4 2022
Q2Q % growth
-2.92
47.86%
-3.030.113.61%
Q3 2022
Q2Q % growth
-3.60
18.18%
-4.490.8919.79%
Q2 2022
Q2Q % growth
-4.80
40.00%
-4.22-0.58-13.86%
Q1 2022
Q2Q % growth
-5.20
40.91%
-3.77-1.43-37.78%
Q4 2021
Q2Q % growth
-5.60
6.67%
-4.90-0.70-14.38%
Q3 2021
Q2Q % growth
-4.40
31.25%
-5.511.1120.12%
Q2 2021
Q2Q % growth
-8.00 -5.61-2.39-42.60%
Q1 2021
Q2Q % growth
-8.80
-10.00%
-6.53-2.27-34.80%
Q4 2020
Q2Q % growth
-6.00 -8.772.7731.60%
Q3 2020
Q2Q % growth
-6.40 -7.941.5419.39%
Q2 2020
Q2Q % growth
-8.00 -8.630.637.34%
Q1 2020
Q2Q % growth
-8.00 -12.174.1734.29%
ELOX Yearly EPS VS EstimatesELOX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -20 -40
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2023
Q2Q % growth
714K-714K-100.00%
Q2 2022
Q2Q % growth
2.38M-2.38M-100.00%
Q1 2022
Q2Q % growth
3.57M-3.57M-100.00%
ELOX Yearly Revenue VS EstimatesELOX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2027 50M 100M 150M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -4.23% -10.63% 4.24%
RevenueN/A -100% N/A -100%